IXAZOMIB for Carcinoid tumour: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where IXAZOMIB was used for Carcinoid tumour.
Most Reported Side Effects for IXAZOMIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 3,249 | 14.6% | 742 | 518 |
| Death | 2,845 | 12.7% | 2,842 | 322 |
| Off label use | 2,841 | 12.7% | 471 | 843 |
| Diarrhoea | 2,560 | 11.5% | 259 | 960 |
| Pneumonia | 1,583 | 7.1% | 276 | 1,143 |
| Nausea | 1,568 | 7.0% | 101 | 489 |
| Fatigue | 1,456 | 6.5% | 131 | 447 |
| Neuropathy peripheral | 1,162 | 5.2% | 54 | 281 |
| Vomiting | 977 | 4.4% | 91 | 390 |
| Thrombocytopenia | 964 | 4.3% | 210 | 403 |
| Rash | 864 | 3.9% | 60 | 270 |
| Platelet count decreased | 848 | 3.8% | 120 | 364 |
| Constipation | 759 | 3.4% | 63 | 272 |
| Asthenia | 728 | 3.3% | 106 | 371 |
| Product dose omission issue | 706 | 3.2% | 53 | 252 |
Other Indications for IXAZOMIB
Plasma cell myeloma (17,602)
Product used for unknown indication (3,402)
Plasma cell myeloma refractory (356)
Amyloidosis (168)
Plasma cell myeloma in remission (165)
Plasma cell myeloma recurrent (116)
Waldenstrom's macroglobulinaemia (54)
Neoplasm malignant (47)
Primary amyloidosis (40)
Plasmacytoma (38)
Other Drugs Used for Carcinoid tumour
OCTREOTIDE (2,148)
TELOTRISTAT ETHYL (1,281)
LANREOTIDE (496)
EVEROLIMUS (270)
SUNITINIB MALATE (61)
LENALIDOMIDE (60)
CABOZANTINIB S-MALATE (56)
CAPECITABINE (50)
TIPIRACIL\TRIFLURIDINE (36)
SANDOSTATIN LAR (34)